These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 38132121)

  • 41. Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.
    Vernocchi P; Gili T; Conte F; Del Chierico F; Conta G; Miccheli A; Botticelli A; Paci P; Caldarelli G; Nuti M; Marchetti P; Putignani L
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The microbiome(s) and cancer: know thy neighbor(s).
    González-Sánchez P; DeNicola GM
    J Pathol; 2021 Jul; 254(4):332-343. PubMed ID: 33723873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.
    Doocey CM; Finn K; Murphy C; Guinane CM
    BMC Microbiol; 2022 Feb; 22(1):53. PubMed ID: 35151278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity.
    Huynh M; Crane MJ; Jamieson AM
    Front Immunol; 2022; 13():1094110. PubMed ID: 36733391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma.
    Pandya G; Kirtonia A; Singh A; Goel A; Mohan CD; Rangappa KS; Pandey AK; Kapoor S; Tandon S; Sethi G; Garg M
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):682-692. PubMed ID: 34051351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The microbiome in the pathogenesis of lung cancer: The role of microbiome in lung cancer pathogenesis.
    Miao S; Qiu H
    APMIS; 2024 Feb; 132(2):68-80. PubMed ID: 37974493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered Gut Microbial Profile Accompanied by Abnormal Fatty Acid Metabolism Activity Exacerbates Endometrial Cancer Progression.
    Zhao SS; Chen L; Yang J; Wu ZH; Wang XY; Zhang Q; Liu WJ; Liu HX
    Microbiol Spectr; 2022 Dec; 10(6):e0261222. PubMed ID: 36227107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC.
    Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S
    J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy.
    Wang M; Yang G; Tian Y; Zhang Q; Liu Z; Xin Y
    Front Immunol; 2023; 14():1183331. PubMed ID: 37457738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Lung Microbiome on the Way to Cancer.
    Kovaleva OV; Romashin D; Zborovskaya IB; Davydov MM; Shogenov MS; Gratchev A
    J Immunol Res; 2019; 2019():1394191. PubMed ID: 31485458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
    El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of lung and gut microbiota on lung cancer pathogenesis.
    Zhao Y; Liu Y; Li S; Peng Z; Liu X; Chen J; Zheng X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2177-2186. PubMed ID: 34018055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unravelling the role of intratumoral bacteria in digestive system cancers: current insights and future perspectives.
    Lu W; Aihaiti A; Abudukeranmu P; Liu Y; Gao H
    J Transl Med; 2024 Jun; 22(1):545. PubMed ID: 38849871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome.
    Xue X; Li R; Chen Z; Li G; Liu B; Guo S; Yue Q; Yang S; Xie L; Zhang Y; Zhao J; Tan R
    Front Immunol; 2023; 14():1235827. PubMed ID: 37691931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies.
    Chen Y; Wang X; Ye Y; Ren Q
    Med Oncol; 2023 Dec; 41(1):25. PubMed ID: 38129370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies.
    Liu W; Pi Z; Wang X; Shang C; Song C; Wang R; He Z; Zhang X; Wan Y; Mao W
    Crit Rev Oncol Hematol; 2024 Apr; 196():104322. PubMed ID: 38460928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
    Peng YM; Luo XM; Chen JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):505-509. PubMed ID: 37248575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer Microbiome; Opportunities and Challenges.
    Nallanchakravarthula S; Amruta N; Ramamurthy C
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):215-229. PubMed ID: 32819239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer.
    Halley A; Leonetti A; Gregori A; Tiseo M; Deng DM; Giovannetti E; Peters GJ
    Anticancer Res; 2020 Sep; 40(9):4807-4818. PubMed ID: 32878769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.